In our model of established B16 tumors, PD-L1 expression significantly increased on tumor-infiltrating CD11b+ and CD11c+ cells as a result of TGFβ1 and TGFβ3 isoform-specific and pan-TGFβ inhibition (Supplementary Fig. 11a, b). The gene discussed is ITGAX; the disease is neoplasm.